Navigation Links
FDA Advisers Renew Review on Whether to Ban Menthol Cigarettes
Date:11/18/2010

moke menthol," said Vargyas. "There is a very strong correlation between being a teenaged smoker and menthol cigarettes."

That's no coincidence, say smoking opponents: The tobacco industry has long targeted youth and minorities for menthol cigarette marketing, even manipulating menthol content in different brands in an effort to recruit new smokers among youth, according to the U.S. National Cancer Institute and the Harvard School of Public Health.

The debate over how menthols should be regulated was last discussed in July, during the second round of hearings held by the tobacco products advisory committee.

The committee was established by the Family Smoking Prevention and Tobacco Control Act, signed into law by President Barack Obama in June 2009. The legislation gave the FDA unprecedented power to restrict the marketing of tobacco products.

While the law bans cigarette makers from adding candy or fruit-like flavors such as clove, cinnamon, vanilla, cocoa or strawberry to cigarettes, legislators hedged when it came to menthols, the most popular flavoring by far.

Although menthol was not banned from cigarettes, the law stressed that nothing prevented it from regulating menthol as well. In fact, the act required the advisory committee to consider menthol cigarettes' impact on public health -- including its use among children and minorities -- as its first order of business.

Anti-smoking advocates say there is no evidence that menthols -- which account for an estimated 33.9 percent of the U.S. cigarette market -- are less deadly than any other cigarette. Research from the University of Medicine and Dentistry of New Jersey suggests that they are more addictive, making it harder for smokers to quit, particularly blacks and Latinos.

During previous hearings, tobacco industry representatives defended their products, saying menthols are no more harmful than other cigarettes and should not be singled out for a ban.

"We do
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. FDA Advisers Urge Stricter Regulation of Tanning Beds
2. FDA to Broaden Disclosure on Advisers Conflicts of Interest
3. FDA Advisers Say Avastin Shouldnt Be Used for Breast Cancer
4. FDA Advisers Divided on Whether to Ban Diet Drug Meridia
5. FDA Advisers Weigh Approval of Genetically Modified Salmon
6. FDA Advisers Consider Approval of Genetically Modified Salmon
7. FDA Advisers Back Anemia Drugs for Kidney Patients
8. FDA Advisers Consider New Lupus Drug
9. FDA Advisers Endorse New Lupus Drug
10. Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement
11. Reed Group and ACOEM Renew Partnership for Return-to-Work and Treatment Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and easy ... treat specific body parts and muscle groups. , IsoComforter, ... use patented cold therapy machine with the innovative IsoTube design ... injuries. IsoComforter has become the industry leader in cold ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and ... relationship in an effort to further promote visibility and adoption ... has long made AMA journals available via its subscription services, ... JAMA Network. , Long known as both a ...
(Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting a list ... policy . , Some types of vehicles cannot be covered ... released blog post to see if their vehicle qualifies for auto ... some of the cars that cannot be covered by a plan. ...
(Date:1/22/2015)... NORCROSS, Ga., USA (PRWEB) January 22, 2015 ... implementing a statewide data management system with support from ... Germany. , The new solution will leverage Hexagon Geospatial’s ... raster and vector data as well as point clouds ...
Breaking Medicine News(10 mins):Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... Despite many research advances, ovarian cancer remains lethal in a ... In a new study, Dr. Joshua LaBaer of the Biodesign ... Paul Lampe, researchers at the Fred Hutchinson Cancer Research Center ... in blood that can identify ovarian cancer before symptoms appear. ...
... Fathers more assertive, moms more helpful when playing with tots, ... different ways mothers and fathers play with their child helps ... is feminine, new research suggests. , The observation stems from ... the U.S. National Institute of Child Health and Human Development ...
... that light beams travel in straight lines and spread through ... around corners. But now researchers at Tel Aviv University are ... of light can indeed be bent in a laboratory setting, ... rays, called "Airy beams," were named after English astronomer Sir ...
... breakdown of oil from the Gulf of Mexico disaster is ... a comprehensive status report that is the cover story in ... C&EN Senior Correspondent Jeff Johnson and Assistant Editor ... officials continue to struggle with how to handle the massive ...
... 16 June 2010: Alcohol consumption is associated ... arthritic conditions including Rheumatoid Arthritis (RA), Osteoarthritis (OA), ... results of a new study presented today at ... League Against Rheumatism in Rome, Italy. Regardless of ...
... ... , ... Father’s Day approaches many men are looking forward to gifts of hand-made cards, refrigerator art, and ... And for those men who are trying to become dads, the day may come packed ...
Cached Medicine News:Health News:Blood relations 2Health News:Blood relations 3Health News:Playtime with Parents May Shape Gender Roles 2Health News:Shining a light around corners 2Health News:Alcohol consumption lowers risk of developing several arthritic conditions 2Health News:7.3 Million US Men and Their Partners Face Fertility Issues 2Health News:7.3 Million US Men and Their Partners Face Fertility Issues 3
(Date:1/23/2015)... 23, 2015 Gem Pharmaceuticals announced today that the ... into the Company,s Phase 2 clinical trial.  This open-label ... lead compound, GPX-150 (an investigational medication), in approximately 30 ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... UPI ), a medical device company that develops, ... dysfunctions, today reported financial results for the fiscal 2015 ... for the Company,s Urgent ®  PC Neuromodulation System grew ... as compared to $3.9 million in the third quarter ...
(Date:1/22/2015)... Institute for Clinical Research, Inc., a clinical research organization ... new textbook,  Translational Research Methods for Diabetes, Obesity and ... scientific publisher. The textbook is the first ... early phase clinical studies of new drugs for diabetes, ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
... 5 /PRNewswire-FirstCall/ Imaging Diagnostic,Systems, Inc., (OTC Bulletin Board: ... systems, announced that CT Laser Mammography (CTLM(R)),results were ... Society for Breast,Health in Tianjin, China, October 18th ... The Congress attracted more than 500 breast ...
... non-responders to previous interferon-based therapy -, - SVR results ... non- responders, with less frequent dosing -, ... the American Association for the Study of Liver Diseases ... (AASLD) -, ROCKVILLE, Ma., Nov. ...
Cached Medicine Technology:Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health 2Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health 3Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 2Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 3Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 4Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 5Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 6
For the qualitative detection of group A streptococcal antigen from throat swabs....
For the qualitative detection of group A Streptococcal antigen from throat swabs...
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of human Chorionic Gonadotrophin (HCG) in urine or urine and serum specimens...
Medicine Products: